Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Total Current Liabilities (2017 - 2026)

Rocket One's (RKTO) quarterly Total Current Liabilities came in at $1.4 million in Q2 2026, up 279.49% year-over-year from $364630.0 in Q2 2025, and down 3.41% quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

Rocket One (RKTO) Total Current Liabilities (2017 - 2026) Analysis & Trends

Rocket One has disclosed Total Current Liabilities across 10 years of filings, most recently posting $1.4 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 279.49% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (up 279.49% YoY), while the FY2025 annual figure was $1.5 million, up 74.77% from the prior year.
  • Total Current Liabilities came in at $1.4 million for Q2 2026 at Rocket One, down from $1.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.7 million in Q2 2023 to a low of $364630.0 in Q2 2025.
  • Average Total Current Liabilities over 5 years is $1.0 million, with a median of $919812.0 recorded in 2022.
  • Year-over-year, Total Current Liabilities tumbled 60.33% in 2024 and soared 279.49% in 2026.
  • Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then slumped by 51.1% to $678657.0 in 2023, then climbed by 22.48% to $831197.0 in 2024, then surged by 74.77% to $1.5 million in 2025, then fell by 4.75% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $1.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.58 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 283.60 Mn
10 Rocket One 13.86 Mn 5.97 Mn - 1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.38 Mn
Mar 31, 2026 1.43 Mn
Dec 31, 2025 1.45 Mn
Sep 30, 2025 1.01 Mn
Jun 30, 2025 364,630.00
Mar 31, 2025 815,299.00
Dec 31, 2024 831,197.00
Sep 30, 2024 810,324.00
Jun 30, 2024 680,816.00
Mar 31, 2024 639,834.00
Dec 31, 2023 678,657.00
Sep 30, 2023 1.58 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 1.01 Mn
Jun 30, 2022 753,672.00
Mar 31, 2022 825,763.00
Dec 31, 2021 867,787.00
Sep 30, 2021 1.61 Mn